Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ahmet Aydin

Concepts (139)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

The timeline below shows the dates (blue tick marks) of publications associated with Ahmet Aydin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ahmet Aydin has written about over time.
BCG Vaccine, 2 publications between 2017 and 2020, average publication date October 2018. Prostatic Neoplasms, 3 publications between 2019 and 2020, average publication date September 2019. Kidney Neoplasms, 5 publications between 2016 and 2021, average publication date November 2019. Immunotherapy, 6 publications between 2017 and 2021, average publication date December 2019. Carcinoma, Renal Cell, 4 publications between 2016 and 2021, average publication date January 2020. Ubiquitin Thiolesterase, 2 publications between 2019 and 2021, average publication date March 2020. Neoadjuvant Therapy, 5 publications between 2017 and 2022, average publication date May 2020. Carcinoma, Squamous Cell, 5 publications between 2019 and 2021, average publication date June 2020. Penile Neoplasms, 6 publications between 2019 and 2021, average publication date June 2020. Urinary Bladder Neoplasms, 7 publications between 2017 and 2022, average publication date August 2020. Carcinoma, Transitional Cell, 3 publications between 2019 and 2022, average publication date September 2020. Indocyanine Green, 1 publications between 2020 and 2020, average publication date October 2020. Lymphocytes, Tumor-Infiltrating, 3 publications between 2021 and 2021, average publication date February 2021. CD8-Positive T-Lymphocytes, 1 publications between 2021 and 2021, average publication date February 2021. Cancer Vaccines, 1 publications between 2021 and 2021, average publication date February 2021. Urothelium, 1 publications between 2021 and 2021, average publication date February 2021. Adrenal Gland Neoplasms, 1 publications between 2023 and 2023, average publication date December 2023. Pheochromocytoma, 1 publications between 2023 and 2023, average publication date December 2023.

To see the data from this visualization as text, click here.
Aydin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description